Crombez Eric 4

What Happened Eric Crombez, a director of Abeona Therapeutics, sold 26,143 shares on May 15, 2026. The weighted average sale price was $5.53 per share (range $5.44–$5.66), for total proceeds of approximately $144,636. This was a sale (not a purchase); sales by insiders are often routine and do not necessarily signal a change in company outlook.

Key Details

• Transaction date: May 15, 2026.
• Transaction type: Open-market sales under SEC code S; weighted average price $5.53; price range $5.44–$5.66 across multiple trades.
• Total proceeds: ~$144,636.
• Shares owned after transaction: Not specified in the provided filing (see the full Form 4 for post-transaction holdings).
• Footnotes: F1 — Shares were sold pursuant to a Rule 10b5-1 trading plan adopted Feb 4, 2026. F2 — Price shown is a weighted average; reporting person can provide a breakdown of shares sold at each price on request.
• Filing timeliness: Reported with the transaction date (timely filing).

Context A 10b5-1 plan means the trades were prearranged and executed under a scheduled plan, which often limits the ability to infer insider sentiment from the sale. For retail investors, purchases typically carry clearer signals than planned or routine sales. For full transaction and holding details, consult the filed Form 4 on the SEC EDGAR site.